Precision Therapeutics (AIPT) Reaches New 12-Month Low at $0.71

Precision Therapeutics Inc (NASDAQ:AIPT)’s share price reached a new 52-week low during trading on Monday . The company traded as low as $0.71 and last traded at $0.78, with a volume of 45433 shares trading hands. The stock had previously closed at $0.76.

Precision Therapeutics (NASDAQ:AIPT) last released its quarterly earnings results on Wednesday, November 14th. The medical instruments supplier reported ($0.19) EPS for the quarter. Precision Therapeutics had a negative net margin of 719.83% and a negative return on equity of 266.54%. The firm had revenue of $0.33 million during the quarter.

COPYRIGHT VIOLATION NOTICE: “Precision Therapeutics (AIPT) Reaches New 12-Month Low at $0.71” was originally posted by Community Financial News and is the sole property of of Community Financial News. If you are reading this piece of content on another publication, it was stolen and republished in violation of U.S. and international copyright law. The original version of this piece of content can be viewed at https://www.com-unik.info/2018/12/03/precision-therapeutics-aipt-reaches-new-12-month-low-at-0-71.html.

About Precision Therapeutics (NASDAQ:AIPT)

Precision Therapeutics Inc provides various healthcare products and services primarily in the United States. The company manufactures environmentally conscious systems for the collection and disposal of infectious fluids that result from surgical procedures and post-operative care. It offers the STREAMWAY Fluid Waste Management system that suctions surgical waste fluid from the patient using standard surgical tubing; and disposables.

Featured Article: Futures Contract

Receive News & Ratings for Precision Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Precision Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on reddit